Medical robotics company Neural Analytics has received the CE Mark for its NeuralBot robotic ultrasound technology.
Designed to automatically adjust the orientation and position of the firm's Lucid M1 transcranial Doppler ultrasound system, NeuralBot can help clinicians noninvasively monitor a patient's brain blood flow characteristics and provide information for diagnosing various neurological disorders, according to the company.
NeuralBot will be commercialized in Europe with Lucid M1 under the branding of Lucid Robotic System, Neural Analytics said.